Movatterモバイル変換


[0]ホーム

URL:


GB2468629B - Method, composition, device for the treatment of amylase malfunctions/inactivity in association with saccharides (mainly polysaccharides) based diseases - Google Patents

Method, composition, device for the treatment of amylase malfunctions/inactivity in association with saccharides (mainly polysaccharides) based diseases

Info

Publication number
GB2468629B
GB2468629BGB0811274AGB0811274AGB2468629BGB 2468629 BGB2468629 BGB 2468629BGB 0811274 AGB0811274 AGB 0811274AGB 0811274 AGB0811274 AGB 0811274AGB 2468629 BGB2468629 BGB 2468629B
Authority
GB
United Kingdom
Prior art keywords
inactivity
saccharides
amylase
malfunctions
association
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0811274A
Other versions
GB0811274D0 (en
GB2468629A (en
Inventor
Tarig Sayed Mustafa Arbab
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Saccharides Science and Tech Ltd
Original Assignee
Saccharides Science and Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0810396Aexternal-prioritypatent/GB0810396D0/en
Application filed by Saccharides Science and Tech LtdfiledCriticalSaccharides Science and Tech Ltd
Priority to US12/165,378priorityCriticalpatent/US20090317371A1/en
Publication of GB0811274D0publicationCriticalpatent/GB0811274D0/en
Priority to CA002661953Aprioritypatent/CA2661953A1/en
Priority to CA002654374Aprioritypatent/CA2654374A1/en
Priority to CA002636864Aprioritypatent/CA2636864A1/en
Priority to GBGB0821501.4Aprioritypatent/GB0821501D0/en
Priority to GB1111470.9Aprioritypatent/GB2479294B/en
Priority to GB0822158Aprioritypatent/GB2465814B/en
Publication of GB2468629ApublicationCriticalpatent/GB2468629A/en
Publication of GB2468629BpublicationCriticalpatent/GB2468629B/en
Application grantedgrantedCritical
Expired - Fee Relatedlegal-statusCriticalCurrent
Anticipated expirationlegal-statusCritical

Links

Classifications

Landscapes

GB0811274A2008-06-082008-06-19Method, composition, device for the treatment of amylase malfunctions/inactivity in association with saccharides (mainly polysaccharides) based diseasesExpired - Fee RelatedGB2468629B (en)

Priority Applications (7)

Application NumberPriority DateFiling DateTitle
US12/165,378US20090317371A1 (en)2008-06-082008-06-30Method, Composition, and Device, for the Treatment of Amylase Malfunctions / Inactivity in Association with Saccharides (Mainly Polysaccharides) Based Diseases
CA002661953ACA2661953A1 (en)2008-06-192008-08-25Method, composition, and device, for the treatment of diseases, enzymes and saccharides disorders
CA002636864ACA2636864A1 (en)2008-06-192008-08-25Method, composition, and device, for the treatment of amylase activity malfunctions / inactivity in association with saccharides (mainly polysaccharides) based diseases
CA002654374ACA2654374A1 (en)2008-06-192008-08-25Method, composition, and device, for the treatment of diseases, enzymes and saccharides disorders
GBGB0821501.4AGB0821501D0 (en)2008-06-082008-11-25Method, composition, and device, for the treatment of enzymes and saccharides disorder
GB1111470.9AGB2479294B (en)2008-06-192008-12-04Method, composition and device for the treatment of enzymes and saccharides disorders
GB0822158AGB2465814B (en)2008-06-192008-12-04Method,composition and device for the treatment of enzymes and saccharides disorders

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
US13517908A2008-06-082008-06-08
GB0810396AGB0810396D0 (en)2008-06-092008-06-09Method, composition, for the treatment of amylase malfunctions/inactivity in association with saccharides (mainly polysaccharides) based diseases

Publications (3)

Publication NumberPublication Date
GB0811274D0 GB0811274D0 (en)2008-07-30
GB2468629A GB2468629A (en)2010-09-15
GB2468629Btrue GB2468629B (en)2011-10-26

Family

ID=39682834

Family Applications (2)

Application NumberTitlePriority DateFiling Date
GB0811274AExpired - Fee RelatedGB2468629B (en)2008-06-082008-06-19Method, composition, device for the treatment of amylase malfunctions/inactivity in association with saccharides (mainly polysaccharides) based diseases
GBGB0821501.4ACeasedGB0821501D0 (en)2008-06-082008-11-25Method, composition, and device, for the treatment of enzymes and saccharides disorder

Family Applications After (1)

Application NumberTitlePriority DateFiling Date
GBGB0821501.4ACeasedGB0821501D0 (en)2008-06-082008-11-25Method, composition, and device, for the treatment of enzymes and saccharides disorder

Country Status (1)

CountryLink
GB (2)GB2468629B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
GB2507472A (en)*2012-09-132014-05-07Ajit Ramanial PatelEnzyme composition for enhancing digestion
WO2017052455A1 (en)2015-09-232017-03-30Anara AbAmylase fragments for blood glucose control
EP3251687A1 (en)2016-06-012017-12-06Centrum Innowacji Edoradca Sp. z o.o. Spolka KomandytowaBioactive peptides for blood glucose control
GB201614415D0 (en)2016-08-242016-10-05Pepsis LtdEnzymes for the treatment of human enterometabolic dysfunction

Citations (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20060061302A1 (en)*2004-09-162006-03-23Toyoda Gosei Co., Ltd.Light source
WO2006136161A2 (en)*2005-06-242006-12-28Novozymes A/SAmylases for pharmaceutical use
WO2006136159A2 (en)*2005-06-242006-12-28Novozymes A/SLipases for pharmaceutical use

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20060061302A1 (en)*2004-09-162006-03-23Toyoda Gosei Co., Ltd.Light source
WO2006136161A2 (en)*2005-06-242006-12-28Novozymes A/SAmylases for pharmaceutical use
WO2006136159A2 (en)*2005-06-242006-12-28Novozymes A/SLipases for pharmaceutical use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
http://www.aace.com/meetings/ams/2007/AACE 16th Annual Meeting & Clinical Congress, April 11-15 2007, 2007 Abstracts, Abstractà327, Arbab & Elias, "Amzylite F1.2 as an in-vitro and in-vivo glucose reducing agent" [accessed 8 October 2008]*

Also Published As

Publication numberPublication date
GB0821501D0 (en)2008-12-31
GB0811274D0 (en)2008-07-30
GB2468629A (en)2010-09-15

Similar Documents

PublicationPublication DateTitle
IL210754A0 (en)Devices, methods, and kits for forming tracts in tissue
IL208518A0 (en)Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
EG26729A (en)Method of propping agent delivery to the well
IL216263A0 (en)Devices, methods and kits for forming tracts in tissue
WO2010062863A3 (en)Compositions containing satiogens and methods of use
IL212707A0 (en)Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
IL218780A0 (en)Devices,, methods, and kits for forming tracts in tissue
IL210755A0 (en)Devices and methods for forming tracts in tissue
IL202424A (en)Telomerase activating compounds for use in treating diseases, disorders and conditions related thereto
EP2318026A4 (en)Composition for controlling increase in blood glucose
IL207720A0 (en)Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
IL205939A (en)Compounds for use in treating lysosomal disorders
ZA201005905B (en)Methods,dosage forms,and kits for administering ziprasidone without food
EP2049899A4 (en)Methods to prevent and treat diseases
GB2465814B (en)Method,composition and device for the treatment of enzymes and saccharides disorders
IL207722A (en)Pyridopyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
GB2468629B (en)Method, composition, device for the treatment of amylase malfunctions/inactivity in association with saccharides (mainly polysaccharides) based diseases
IL207647A0 (en)Use of interleukin-1 conjugates in the treatment of diabetes
ZA201007982B (en)Gear pumps and methods for using gear pumps
PL2268624T3 (en)Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
GB0810396D0 (en)Method, composition, for the treatment of amylase malfunctions/inactivity in association with saccharides (mainly polysaccharides) based diseases
WO2009089070A9 (en)Compositions and methods for reducing particle penetration through mucus
GB2479294B (en)Method, composition and device for the treatment of enzymes and saccharides disorders
HK1148964A (en)Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
HK1158182A (en)Compounds, pharmaceutical composition and methods for use in treating metabolic disorders

Legal Events

DateCodeTitleDescription
PCNPPatent ceased through non-payment of renewal fee

Effective date:20190619


[8]ページ先頭

©2009-2025 Movatter.jp